Hair Loss - High Priority Clinical Need

Hair loss can have severe negative effects on people undergoing chemotherapy treatment, with 8% of potential patients refusing or avoiding treatment due to their fear of hair loss. Over 4 million patients worldwide affected by chemotherapy induced alopecia annually, making now the time to act.


Luminate Medical recognises that hair is an essential element of personality and self-esteem, and is dedicated to using the latest advances in medical technology to protect this. 

A New Solution

The need was observed during the clinical immersion phase of the BioInnovate programme in NUI Galway. The clear appetite for change amongst patients, clinicians and support groups has lead to the development of a novel and disruptive technological solution by the Luminate Medical team. To find out more about our approach, reach out to us via the Contact page.